Home › Funds › WESTPAC BANKING CORP › REGN

WESTPAC BANKING CORP position in REGN

REGENERON PHARMACEUTICALS · Health Care

WESTPAC BANKING CORP reported holding 13,637 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 0.63% of its reported portfolio and ranking #25 among its reported holdings. WESTPAC BANKING CORP has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.64K sh
Reported value held$10.34M
Portfolio Weight0.63%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WESTPAC BANKING CORP's REGN position evolved

WESTPAC BANKING CORP first disclosed a stake in REGN in Q3 2023 at 698 shares (US$574K). The position peaked in Q3 2026 at 13,637 shares, worth US$10.3M. Across 13 filings, WESTPAC BANKING CORP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 13,637 shares valued at US$10.3M — an increase of 6,578 shares quarter over quarter.. Notable position changes include a 745% increase in Q4 2025 (shares were roughly flat over the following quarter), a 39% increase in Q1 2026 (shares fell 18% over the following quarter), a 93% increase in Q3 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 698 $574.43K New
Q4 2023 861 $756.21K Add
Q1 2024 843 $811.38K Reduce
Q2 2024 923 $970.10K Add
Q3 2024 989 $1.04M Add
Q4 2024 989 $704.49K Hold
Q1 2025 831 $527.04K Reduce
Q2 2025 815 $427.88K Reduce
Q3 2025 815 $458.25K Hold
Q4 2025 6.89K $5.32M Add
Q1 2026 9.60K $7.42M Add
Q2 2026 7.06K $4.40M Reduce
Q3 2026 13.64K $10.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has WESTPAC BANKING CORP held REGN?

WESTPAC BANKING CORP has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WESTPAC BANKING CORP's current position in REGN?

As of Q3 2026, WESTPAC BANKING CORP holds 13.64K shares of REGN (REGENERON PHARMACEUTICALS), valued at $10.34M, representing 0.63% of its reported portfolio and ranking #25.

Has WESTPAC BANKING CORP been buying or selling REGN?

In the latest 13F filing (Q3 2026), WESTPAC BANKING CORP increased its position in REGN. The position peaked in Q3 2026 at 13.64K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.